Top 17 Hydra Biosciences investors
The most complete profiles first. Showing 17 of 17.
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Marc GoldbergVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AHealth CareTelecommunicationsConsumer ResearchWellnessPortfolio: Ardais Corporation, Hydrocision, Nano-Micro Technology, Sciona and 19 more
Verified email available
Peter FeinsteinVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AHealth CareTelecommunicationsConsumer ResearchWellnessPortfolio: Ardais Corporation, Hydrocision, Nano-Micro Technology, Sciona and 19 more
Verified email available
Tony LyonsVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AHealth CareTelecommunicationsConsumer ResearchWellnessPortfolio: Ardais Corporation, Hydrocision, Nano-Micro Technology, Sciona and 19 more
Contact details available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Alan CraneVerified
Venture Capital · United States
Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 82 more
Verified email available
Bill WibergVerified
Venture Capital · United States
Health CareHospitalsE-commerceWomen FoundedPortfolio: Zeltiq Aesthetics, Modria, Ardian, ChannelAdvisor and 43 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Ed Torres
Corporate Venture Capital · United States
Health CareAlternative MedicineWomen FoundedInformation Technology (IT)Portfolio: Avid Radiopharmaceuticals, GlobeImmune, Sutro Biopharma, Cerulean Pharma and 30 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Jonathan Macquitty
Venture Capital, Private Equity Firm, Angel/Individual · United States
Series BHealth CareE-commerceEnterprise SoftwareAndroidPortfolio: Labcyte, Hydra Biosciences, Labcyte Inc., Adiana and 1 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Valeritas11
- Gynesonics11
- Labcyte11
- Portola Pharmaceuticals11
- Avila Therapeutics10
- Soleno Therapeutics10
- Personalis10
- Q32 Bio10
- Algeta10
- Pixium Vision10
- Nouscom10
Frequently asked questions
How many Hydra Biosciences investors are on Angel Roster?
Angel Roster lists 17 Hydra Biosciences investors. 8 of them (47%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (16), Private Equity Firms (8) and Micro VC Firms (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Hydra Biosciences investors invest in?
Among those that list a stage, the most common are Series B (10) and Series A (3).
Where are Hydra Biosciences investors based?
Most are based in the United States (12) and the United Kingdom (5).
Which companies have Hydra Biosciences investors backed?
The most-backed portfolio companies among them are Valeritas (11), Gynesonics (11), Labcyte (11), Portola Pharmaceuticals (11) and Avila Therapeutics (10).
How do I contact Hydra Biosciences investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.